Record Details

Present Status of Antileishmanial Vaccines

EPrints@IICB

View Archive Info
 
 
Field Value
 
Title Present Status of Antileishmanial Vaccines
 
Creator Ghosh, Monidipa
Bandyopadhyay, Santu
 
Subject Infectious Diseases and Immunology
 
Description The term leishmaniasis refers collectively to various clinical syndromes that are caused by obligate intracellular protozoa of
the genus Leishmania. Approximately 350 million people in 8 countries are estimated to be threatened by the disease [1]. The
World Health Organization estimated that there are 12 million cases of all forms of leishmaniasis worldwide, with over 500,000
new cases of visceral disease occurring each year [1]. Most of the drugs commonly used to treat different forms of leishmaniasis
are toxic and have unacceptable side effects. Moreover, cases of drug resistant leishmaniasis are on the rise. Due to nonexistence
of effective vaccine to date, improved immunoprophylactic approaches still remain desirable to combat leishmaniasis.
Antileishmanial vaccines developed around the globe are discussed.
 
Date 2003
 
Type Article
PeerReviewed
 
Format application/pdf
 
Identifier http://www.eprints.iicb.res.in/1629/1/Molecular_and_cellular_biochemistry%2C_2003.pdf
Ghosh, Monidipa and Bandyopadhyay, Santu (2003) Present Status of Antileishmanial Vaccines. Molecular and Cellular Biochemistry, 253. pp. 199-205.
 
Relation http://dx.doi.org/10.1023/A:1026047429604
http://www.eprints.iicb.res.in/1629/